Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Rades

Showing results (111-120 of 608) with videos related to

Pageof 61
Sort By:
Anticancer Research|March 19, 2017
A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder CancerDirk Rades, Lisa Manig, Stefan Janssen, et al.
Anticancer Research|August 30, 2023
Development of Distress During a Radiotherapy Course for Head-and-neck CancerDirk Rades, Cansu Delikanli, Nathan Y Yu, et al.
Anticancer Research|June 23, 2023
Hypo-fractionated Radiotherapy (HF-RT) <i>Versus</i> Conventionally Fractionated Radiotherapy (CF-RT) for GlioblastomaOksana Zemskova, Eugene Pedachenko, Nathan Y Yu, et al.
Anticancer Research|May 29, 2023
Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain MetastasesDirk Rades, Leonie Johannwerner, Nathan Y Yu, et al.
Anticancer Research|May 29, 2017
Radiotherapy of Primary or Recurrent Bladder Cancer in the Very ElderlyStefan Janssen, Lisa Manig, Steven E Schild, et al.
Cancer|July 20, 2007
Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastasesDirk Rades, Tiina Haatanen, Steven E Schild, et al.
In Vivo (Athens, Greece)|December 26, 2023
Distress Scores in Elderly Cancer Patients During RadiotherapyDirk Rades, Cansu Delikanli, Nathan Y Yu, et al.
Anticancer Research|January 2, 2020
A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal CancerRapha Haus, Stefan Janssen, Steven E Schild, et al.
In Vivo (Athens, Greece)|March 1, 2020
Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney CancerDirk Rades, Rapha Haus, Stefan Janssen, et al.
Anticancer Research|June 9, 2016
Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain MetastasesDirk Rades, Stefan Janssen, Theo Veninga, et al.
Pageof 61

Showing results (111-120 of 608) with videos related to

Sort By:
Pageof 61
Anticancer Research|March 19, 2017
A Survival Score for Patients Assigned to Palliative Radiotherapy for Metastatic Bladder CancerDirk Rades, Lisa Manig, Stefan Janssen, et al.
Anticancer Research|August 30, 2023
Development of Distress During a Radiotherapy Course for Head-and-neck CancerDirk Rades, Cansu Delikanli, Nathan Y Yu, et al.
Anticancer Research|June 23, 2023
Hypo-fractionated Radiotherapy (HF-RT) <i>Versus</i> Conventionally Fractionated Radiotherapy (CF-RT) for GlioblastomaOksana Zemskova, Eugene Pedachenko, Nathan Y Yu, et al.
Anticancer Research|May 29, 2023
Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain MetastasesDirk Rades, Leonie Johannwerner, Nathan Y Yu, et al.
Anticancer Research|May 29, 2017
Radiotherapy of Primary or Recurrent Bladder Cancer in the Very ElderlyStefan Janssen, Lisa Manig, Steven E Schild, et al.
Cancer|July 20, 2007
Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastasesDirk Rades, Tiina Haatanen, Steven E Schild, et al.
In Vivo (Athens, Greece)|December 26, 2023
Distress Scores in Elderly Cancer Patients During RadiotherapyDirk Rades, Cansu Delikanli, Nathan Y Yu, et al.
Anticancer Research|January 2, 2020
A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal CancerRapha Haus, Stefan Janssen, Steven E Schild, et al.
In Vivo (Athens, Greece)|March 1, 2020
Interval Between Cancer Diagnosis and Radiotherapy - An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney CancerDirk Rades, Rapha Haus, Stefan Janssen, et al.
Anticancer Research|June 9, 2016
Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain MetastasesDirk Rades, Stefan Janssen, Theo Veninga, et al.
Pageof 61